Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical Study
Phase 1
Completed
- Conditions
- Cough
- Interventions
- First Posted Date
- 2015-10-08
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- Nexgen Pharma, Inc
- Target Recruit Count
- 38
- Registration Number
- NCT02572375
- Locations
- 🇯🇴
Pharmaceutical Research Unit, Amman, Jordan
Single Dose Trial of Extended Release Combination Tablet Codeine and Guaifenesin
Phase 1
Completed
- Conditions
- Cough
- Interventions
- Drug: ER Tablet under Fasted ConditionsDrug: ER Tablet under Fed ConditionsDrug: IR Tablet under Fasted conditions
- First Posted Date
- 2014-06-06
- Last Posted Date
- 2015-04-15
- Lead Sponsor
- Nexgen Pharma, Inc
- Target Recruit Count
- 26
- Registration Number
- NCT02157649
- Locations
- 🇯🇴
Pharmaceutical Research Unit, Amman, Jordan
© Copyright 2025. All Rights Reserved by MedPath